| Medical and Health Sciences | 2021-2025 | 223 | IN 2 | 99.96 |
| Nephrology | Lifetime | 31 | IN 2 | 99.75 |
| Finance and Banking | Lifetime | 128 | IN 1 | 99.31 |
| Public, Environmental and Occupational Health | Lifetime | 598 | IN 5 | 99.17 |
| Transplantation | Lifetime | 144 | IN 2 | 95.52 |
| Emergency Medical Services | Lifetime | 710 | IN 4 | 92.01 |
| Nephrology | 2021-2025 | 6 | IN 1 | 99.88 |
| General Health Professions | 2021-2025 | 520 | IN 2 | 95.89 |
| Public, Environmental and Occupational Health | 2021-2025 | 571 | IN 10 | 94.51 |
| Infectious Diseases | 2021-2025 | 434 | IN 4 | 91.05 |
| Pulmonary and Respiratory Medicine | 2021-2025 | 799 | IN 10 | 89.48 |
| Hematology | 2021-2025 | 266 | IN 1 | 89.08 |
| Cardiology and Cardiovascular Medicine | 2021-2025 | 809 | IN 5 | 84.01 |
| Health, Toxicology and Mutagenesis | 2021-2025 | 753 | IN 14 | 81.84 |
| Transplantation | 2021-2025 | 100 | IN 2 | 78.12 |
| Endocrinology, Diabetes and Metabolism | 2021-2025 | 566 | IN 7 | 78.94 |
| Pathology and Forensic Medicine | 2021-2025 | 554 | IN 11 | 67.53 |
| Organizational Behavior and Human Resource Management | 2021-2025 | 637 | IN 17 | 57.95 |
| Healthcare Systems and Reforms | Lifetime | 7 | IN 1 | 99.68 |
| Organ Donation and Transplantation | Lifetime | 17 | IN 2 | 99.70 |
| Dialysis and Renal Disease Management | Lifetime | 35 | IN 1 | 99.76 |
| Chronic Kidney Disease and Diabetes | Lifetime | 46 | IN 2 | 99.62 |
| Renal and Vascular Pathologies | Lifetime | 71 | IN 1 | 99.32 |
| COVID-19 and healthcare impacts | Lifetime | 115 | IN 3 | 97.79 |
| Renal Diseases and Glomerulopathies | Lifetime | 110 | IN 1 | 99.23 |
| Renal Transplantation Outcomes and Treatments | Lifetime | 147 | IN 3 | 99.18 |
| COVID-19 Clinical Research Studies | Lifetime | 481 | IN 8 | 98.11 |
| Acute Kidney Injury Research | Lifetime | 112 | IN 2 | 98.50 |
| Healthcare cost, quality, practices | Lifetime | 193 | IN 1 | 97.31 |
| Global Maternal and Child Health | Lifetime | 630 | IN 18 | 97.79 |
| Blood Pressure and Hypertension Studies | Lifetime | 933 | IN 4 | 97.53 |
| Central Venous Catheters and Hemodialysis | Lifetime | 502 | IN 3 | 96.66 |
| Organ and Tissue Transplantation Research | Lifetime | 211 | IN 1 | 95.49 |
| Drug-Induced Hepatotoxicity and Protection | Lifetime | 671 | IN 24 | 95.59 |
| Nephrotoxicity and Medicinal Plants | Lifetime | 71 | IN 1 | 93.90 |
| Global Public Health Policies and Epidemiology | Lifetime | 518 | IN 25 | 94.70 |
| Amyloidosis: Diagnosis, Treatment, Outcomes | Lifetime | 760 | IN 2 | 92.93 |
| Erythropoietin and Anemia Treatment | Lifetime | 534 | IN 2 | 92.83 |
| Muscle and Compartmental Disorders | Lifetime | 499 | IN 6 | 91.63 |
| Potassium and Related Disorders | Lifetime | 854 | IN 4 | 86.30 |
| Global Health and Epidemiology | Lifetime | 692 | IN 176 | 65.55 |
| Dialysis and Renal Disease Management | 2021-2025 | 2 | IN 1 | 99.84 |
| Renal and Vascular Pathologies | 2021-2025 | 9 | IN 1 | 99.14 |
| Chronic Kidney Disease and Diabetes | 2021-2025 | 14 | IN 1 | 99.56 |
| Renal Diseases and Glomerulopathies | 2021-2025 | 26 | IN 1 | 99.11 |
| Organ Donation and Transplantation | 2021-2025 | 18 | IN 2 | 98.62 |
| COVID-19 and healthcare impacts | 2021-2025 | 137 | IN 3 | 96.92 |
| COVID-19 Clinical Research Studies | 2021-2025 | 394 | IN 10 | 98.15 |
| Health Systems, Economic Evaluations, Quality of Life | 2021-2025 | 335 | IN 3 | 96.77 |
| Global Health Care Issues | 2021-2025 | 112 | IN 5 | 93.67 |
| Healthcare cost, quality, practices | 2021-2025 | 66 | IN 1 | 94.23 |
| Long-Term Effects of COVID-19 | 2021-2025 | 946 | IN 10 | 93.17 |
| Healthcare Systems and Reforms | 2021-2025 | 140 | IN 20 | 93.57 |
| Acute Kidney Injury Research | 2021-2025 | 150 | IN 5 | 93.50 |
| Central Venous Catheters and Hemodialysis | 2021-2025 | 175 | IN 1 | 92.57 |
| Renal Transplantation Outcomes and Treatments | 2021-2025 | 406 | IN 4 | 92.99 |
| Erythropoietin and Anemia Treatment | 2021-2025 | 69 | IN 1 | 92.66 |
| Climate Change and Health Impacts | 2021-2025 | 970 | IN 9 | 87.38 |
| Iron Metabolism and Disorders | 2021-2025 | 411 | IN 15 | 88.58 |
| Potassium and Related Disorders | 2021-2025 | 414 | IN 2 | 71.12 |
| Sodium Intake and Health | 2021-2025 | 612 | IN 12 | 66.83 |
| Thermal Regulation in Medicine | 2021-2025 | 985 | IN 17 | 54.15 |
| Muscle and Compartmental Disorders | 2021-2025 | 732 | IN 9 | 52.19 |
| Fluoride Effects and Removal | 2021-2025 | 846 | IN 154 | 49.27 |
| Biomedical Research and Pathophysiology | 2021-2025 | 829 | IN 13 | 30.80 |
| Climate Change and Geoengineering | 2021-2025 | 530 | IN 6 | 25.31 |
